| Identification | Back Directory | [Name]
1H-Indole-3-acetamide, N-[(1S)-1-(aminocarbonyl)-2,2-dimethylpropyl]-1-[(4-fluorophenyl)methyl]- | [CAS]
2938025-73-9 | [Synonyms]
1H-Indole-3-acetamide, N-[(1S)-1-(aminocarbonyl)-2,2-dimethylpropyl]-1-[(4-fluorophenyl)methyl]- | [Molecular Formula]
C23H26FN3O2 | [MOL File]
2938025-73-9.mol | [Molecular Weight]
395.47 |
| Chemical Properties | Back Directory | [Boiling point ]
674.3±55.0 °C(Predicted) | [density ]
1.19±0.1 g/cm3(Temp: 20 °C; Press: 760 Torr)(Predicted) | [solubility ]
DMF: 5 mg/ml
DMSO: 10 mg/ml
DMSO: PBS (pH 7.2) (1:1): 0.5 mg/ml
Ethanol: 2 mg/ml | [pka]
14.27±0.46(Predicted) |
| Hazard Information | Back Directory | [Description]
ADB-FUBIATA (Item No. 35059) is an analytical reference standard categorized as a synthetic cannabinoid.1 This product is intended for research and forensic applications.WARNING This product is not for human or veterinary use. | [References]
[1] CAITLYN NORMAN. In vitro cannabinoid receptor activity, metabolism, and detection in seized samples of CH-PIATA, a new indole-3-acetamide synthetic cannabinoid[J]. Drug Testing and Analysis, 2023, 16 4: 380-391. DOI: 10.1002/dta.3555
[2] MARIE H. DEVENTER. A new cannabinoid receptor 1 selective agonist evading the 2021 “China ban”: ADB-FUBIATA[J]. Drug Testing and Analysis, 2022, 14 9: 1639-1644. DOI: 10.1002/dta.3285 |
|
|